Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159842 · ClinicalTrials.gov registry record · Phase 2
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
A Phase 2 study, sponsored by The Center for Clinical and Cosmetic Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT06159842 is a Phase 2 study that has completed, run by The Center for Clinical and Cosmetic Research. The registered enrollment target is 32 participants.
The verdict
NCT06159842, a Phase 2 study, has completed, sponsored by The Center for Clinical and Cosmetic Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive cream used in combination with a light source. The main questions this trial aims to answer are: * to confirm using laboratory testing, how much of the affected facial skin cancer section the treatment was able to remove, and; * seeing how many participants had no remaining affected facial skin cancer sections after treatment. Participants who qualify will be asked to complete 12 visits in total and will receive a total of two treatments, after voluntarily consent has been given.
Interventions
- COMBINATION_PRODUCT Aminolevulinic Acid 20% Topical Solution with Blue Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2024-11-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06159842
The ClinicalTrials.gov registry entry for NCT06159842 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Clinical and Cosmetic Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aminolevulinic Acid 20% Topical Solution with Blue Light is the first listed.
NCT06159842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06159842 about?
NCT06159842 is a clinical study titled "Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)". The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive cream used in combination with a light source. The main questions this trial aims to answer are: * to confirm using laborat...
What is the current status of trial NCT06159842?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2023-08-08. Estimated completion is 2024-11-13.
What interventions are being tested in trial NCT06159842?
The interventions under investigation include: Aminolevulinic Acid 20% Topical Solution with Blue Light (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06159842?
This trial is sponsored by The Center for Clinical and Cosmetic Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.